[342 Pages Report] The global patient recliners market is valued at about US$ 14.8 Billion in 2022. As per the estimates, the patient recliners market size is likely to reach a net worth of US$ 35.1 Billion by the year 2032, by growing at a CAGR of 8.1% during the forecast period (2022-2032).
| Report Attribute | Details |
|---|---|
| Patient Recliners Market Size Value (2022) | US$ 14.8 Billion |
| Patient Recliners Market Share Anticipated Forecast Value (2032) | US$ 35.1 Billion |
| Projected Patient Recliners Market Growth Rate (2022-2032) | 8.1% |
The patient recliner is an important furniture staple of the patient rooms and is becoming common in hospitals, patient examination areas, physician’s offices, and therapy centres. These patient recliners or recliner chairs provide many benefits for short-term as well as long-term patients by maximizing their comfort.
The growing demand for patient recliners witnessed in the present-day healthcare sector was first developed and used by La-Z-Boy, but the design was bulky and somewhat complicated. Despite this, the earliest design is still dominant and has shown a little evolution, as evident from the sales of patient recliners achieved in the contemporary market.
Functional challenges were due to bulky arms and footprint, which were solved after the introduction of Nemschoff’s award-winning patient recliner AVA, which has significantly strengthened the patient recliner market share.
The current global patient recliners market makes available a variety of products with different features such as posture-correct lumbar and lateral cushioning and wire-spring construction for easy suspension. Anti-bacterial easy cleaning polyvinyl cushioning, etc., are some of the recent adoptions that have boosted the sales of patient recliners as well.
Demand for patient recliners is increasing for a variety of sizes and functions, including deep recline and adjustable suspension. The need for providing stress reduction and improvement of blood circulation in the limbs has also surged the sales of patient recliners in the last couple of years.
Over the projection period, the patient room recliners sector is anticipated to generate the most revenue. Load capacity, adaptability, and improved comfort for both the inpatient and staff are to blame for the higher sales of patient recliners in this segment. The demand for patient recliners in the bariatric recliners segment, on the other hand, is anticipated to witness a sharp rise during the projected years.
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
Increased safety for both patients as well as caregivers is the prime requirement of any medical equipment that is generating a huge demand for patient recliners as well. The global patient recliners market is expected to witness steady and continuous growth over the forecast period of 2017–2027 due to the growing number of private as well as public healthcare facilities across the globe.
Sales of patient recliners for home care settings are expected to increase with increasing disposable income and to improve the standard of living in both developed as well as emerging markets.
Expanding aging population and higher footfall in hospitals are the major factors driving the sales of patient recliners market over the last few years. Technological advancements and enhanced functionality of modern assets would significantly drive the demand for patient recliners over the forecast period.
For instance, ergonomically mapped recliners designed to relieve pressure are widely getting adopted by the US patient recliners market share these days. However, most of the sales of patient recliners in today’s market are achieved by typical ones that are hard to move despite the fact that they are equipped with casters.
Moreover, aesthetic and functional issues are also limiting the demand for patient recliners by healthcare institutions. However, recent advances have made the shifting of patients from recliners to wheelchairs, beds, or other patient transfer devices easier, which has supplemented the demand for patient recliners further.
Geographically, the demand for patient recliners is highest in the North America region, accounting for almost 37.5% achieved globally. The US clearly dominates the global patient recliners market due to the highest standard of healthcare. Europe is figured out to be the second-largest market for sales of patient recliners contributing to nearly 33.4% due to more number of key players operating in the region.
Asia Pacific patient recliners market is expected to witness considerable growth in demand for patient recliners due to rapid acceptance of these products by the growing aging population. Higher installation and maintenance costs are the major factors and challenges for the sales of patient recliners in Asia Pacific countries.
Principal Consultant
Some of the popular players in the patient recliners market include Jordan Active Patient Recliner (Krug Inc.), Ava, Serenity (Nemschoff), Accord Wieland, versant (Sauder MFG Co.), Affina, Perth, Soltice (KI), and Symmetry Plus (Stryker) among others.
| Report Attribute | Details |
|---|---|
| Growth Rate | CAGR of 8.1% from 2022 to 2032 |
| Base Year for Estimation | 2021 |
| Historical Data | 2016-2021 |
| Forecast Period | 2022-2032 |
| Quantitative Units | Revenue in US$ Million and CAGR from 2022-2032 |
| Report Coverage | Revenue Forecast, Volume Forecast, Company Ranking, Competitive Landscape, Growth Factors, Trends and Pricing Analysis |
| Segments Covered |
|
| Regions Covered |
|
| Key Countries Profiled |
|
| Key Companies Profiled |
|
| Customization | Available Upon Request |
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
The global patient recliners market is set to advance at a CAGR of 8.1% from 2022 to 2032.
North America dominates patient recliners market share of 37.5% through 2032.
The patient recliners market is likely to reach a valuation of US$ 35.1 Billion by 2032.
1. Executive Summary 1.1. Global Market Outlook 1.2. Demand-side Trends 1.3. Supply-side Trends 1.4. Technology Roadmap Analysis 1.5. Analysis and Recommendations 2. Market Overview 2.1. Market Coverage / Taxonomy 2.2. Market Definition / Scope / Limitations 3. Market Background 3.1. Market Dynamics 3.1.1. Drivers 3.1.2. Restraints 3.1.3. Opportunity 3.1.4. Trends 3.2. Scenario Forecast 3.2.1. Demand in Optimistic Scenario 3.2.2. Demand in Likely Scenario 3.2.3. Demand in Conservative Scenario 3.3. Opportunity Map Analysis 3.4. Investment Feasibility Matrix 3.5. PESTLE and Porter’s Analysis 3.6. Regulatory Landscape 3.6.1. By Key Regions 3.6.2. By Key Countries 3.7. Regional Parent Market Outlook 4. Global Market Analysis 2017-2021 and Forecast, 2022-2032 4.1. Historical Market Size Value (US$ Mn) Analysis, 2017-2021 4.2. Current and Future Market Size Value (US$ Mn) Projections, 2022-2032 4.2.1. Y-o-Y Growth Trend Analysis 4.2.2. Absolute $ Opportunity Analysis 5. Global Market Analysis 2017-2021 and Forecast 2022-2032, By Indication 5.1. Introduction / Key Findings 5.2. Historical Market Size Value (US$ Mn) Analysis By Indication, 2017-2021 5.3. Current and Future Market Size Value (US$ Mn) Analysis and Forecast By Indication, 2022-2032 5.3.1. Cardiac Care Recliners 5.3.2. Bariatric Recliners 5.3.3. Patient Room/Lounge Recliners 5.3.4. Others 5.4. Y-o-Y Growth Trend Analysis By Indication, 2017-2021 5.5. Absolute $ Opportunity Analysis By Indication, 2022-2032 6. Global Market Analysis 2017-2021 and Forecast 2022-2032, By End User 6.1. Introduction / Key Findings 6.2. Historical Market Size Value (US$ Mn) Analysis By End User, 2017-2021 6.3. Current and Future Market Size Value (US$ Mn) Analysis and Forecast By End User, 2022-2032 6.3.1. Hospitals 6.3.2. Clinics 6.3.3. Dialysis Centers 6.3.4. Nursing Homes 6.3.5. Home Care Settings 6.3.6. Other Healthcare Facilities 6.4. Y-o-Y Growth Trend Analysis By End User, 2017-2021 6.5. Absolute $ Opportunity Analysis By End User, 2022-2032 7. Global Market Analysis 2017-2021 and Forecast 2022-2032, By Region 7.1. Introduction 7.2. Historical Market Size Value (US$ Mn) Analysis By Region, 2017-2021 7.3. Current Market Size Value (US$ Mn) Analysis and Forecast By Region, 2022-2032 7.3.1. North America 7.3.2. Latin America 7.3.3. Europe 7.3.4. Asia Pacific 7.3.5. MEA 7.4. Market Attractiveness Analysis By Region 8. North America Market Analysis 2017-2021 and Forecast 2022-2032, By Country 8.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021 8.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032 8.2.1. By Country 8.2.1.1. US 8.2.1.2. Canada 8.2.2. By Indication 8.2.3. By End User 8.3. Market Attractiveness Analysis 8.3.1. By Country 8.3.2. By Indication 8.3.3. By End User 8.4. Key Takeaways 9. Latin America Market Analysis 2017-2021 and Forecast 2022-2032, By Country 9.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021 9.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032 9.2.1. By Country 9.2.1.1. Brazil 9.2.1.2. Mexico 9.2.1.3. Rest of Latin America 9.2.2. By Indication 9.2.3. By End User 9.3. Market Attractiveness Analysis 9.3.1. By Country 9.3.2. By Indication 9.3.3. By End User 9.4. Key Takeaways 10. Europe Market Analysis 2017-2021 and Forecast 2022-2032, By Country 10.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021 10.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032 10.2.1. By Country 10.2.1.1. Germany 10.2.1.2. U.K. 10.2.1.3. France 10.2.1.4. Spain 10.2.1.5. Italy 10.2.1.6. Rest of Europe 10.2.2. By Indication 10.2.3. By End User 10.3. Market Attractiveness Analysis 10.3.1. By Country 10.3.2. By Indication 10.3.3. By End User 10.4. Key Takeaways 11. Asia Pacific Market Analysis 2017-2021 and Forecast 2022-2032, By Country 11.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021 11.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032 11.2.1. By Country 11.2.1.1. China 11.2.1.2. Japan 11.2.1.3. South Korea 11.2.1.4. Rest of Asia Pacific 11.2.2. By Indication 11.2.3. By End User 11.3. Market Attractiveness Analysis 11.3.1. By Country 11.3.2. By Indication 11.3.3. By End User 11.4. Key Takeaways 12. MEA Market Analysis 2017-2021 and Forecast 2022-2032, By Country 12.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021 12.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032 12.2.1. By Country 12.2.1.1. GCC Countries 12.2.1.2. South Africa 12.2.1.3. Israel 12.2.1.4. Rest of MEA 12.2.2. By Indication 12.2.3. By End User 12.3. Market Attractiveness Analysis 12.3.1. By Country 12.3.2. By Indication 12.3.3. By End User 12.4. Key Takeaways 13. Key Countries Market Analysis 13.1. US 13.1.1. Pricing Analysis 13.1.2. Market Share Analysis, 2021 13.1.2.1. By Indication 13.1.2.2. By End User 13.2. Canada 13.2.1. Pricing Analysis 13.2.2. Market Share Analysis, 2021 13.2.2.1. By Indication 13.2.2.2. By End User 13.3. Brazil 13.3.1. Pricing Analysis 13.3.2. Market Share Analysis, 2021 13.3.2.1. By Indication 13.3.2.2. By End User 13.4. Mexico 13.4.1. Pricing Analysis 13.4.2. Market Share Analysis, 2021 13.4.2.1. By Indication 13.4.2.2. By End User 13.5. Germany 13.5.1. Pricing Analysis 13.5.2. Market Share Analysis, 2021 13.5.2.1. By Indication 13.5.2.2. By End User 13.6. U.K. 13.6.1. Pricing Analysis 13.6.2. Market Share Analysis, 2021 13.6.2.1. By Indication 13.6.2.2. By End User 13.7. France 13.7.1. Pricing Analysis 13.7.2. Market Share Analysis, 2021 13.7.2.1. By Indication 13.7.2.2. By End User 13.8. Spain 13.8.1. Pricing Analysis 13.8.2. Market Share Analysis, 2021 13.8.2.1. By Indication 13.8.2.2. By End User 13.9. Italy 13.9.1. Pricing Analysis 13.9.2. Market Share Analysis, 2021 13.9.2.1. By Indication 13.9.2.2. By End User 13.10. China 13.10.1. Pricing Analysis 13.10.2. Market Share Analysis, 2021 13.10.2.1. By Indication 13.10.2.2. By End User 13.11. Japan 13.11.1. Pricing Analysis 13.11.2. Market Share Analysis, 2021 13.11.2.1. By Indication 13.11.2.2. By End User 13.12. South Korea 13.12.1. Pricing Analysis 13.12.2. Market Share Analysis, 2021 13.12.2.1. By Indication 13.12.2.2. By End User 13.13. GCC Countries 13.13.1. Pricing Analysis 13.13.2. Market Share Analysis, 2021 13.13.2.1. By Indication 13.13.2.2. By End User 13.14. South Africa 13.14.1. Pricing Analysis 13.14.2. Market Share Analysis, 2021 13.14.2.1. By Indication 13.14.2.2. By End User 13.15. Israel 13.15.1. Pricing Analysis 13.15.2. Market Share Analysis, 2021 13.15.2.1. By Indication 13.15.2.2. By End User 14. Market Structure Analysis 14.1. Competition Dashboard 14.2. Competition Benchmarking 14.3. Market Share Analysis of Top Players 14.3.1. By Regional 14.3.2. By Indication 14.3.3. By End User 15. Competition Analysis 15.1. Competition Deep Dive 15.1.1. Stryker Corporation 15.1.1.1. Overview 15.1.1.2. Product Portfolio 15.1.1.3. Profitability by Market Segments 15.1.1.4. Sales Footprint 15.1.1.5. Strategy Overview 15.1.1.5.1. Marketing Strategy 15.1.2. Medline Industries Inc. 15.1.2.1. Overview 15.1.2.2. Product Portfolio 15.1.2.3. Profitability by Market Segments 15.1.2.4. Sales Footprint 15.1.2.5. Strategy Overview 15.1.2.5.1. Marketing Strategy 15.1.3. Regency Healthcare 15.1.3.1. Overview 15.1.3.2. Product Portfolio 15.1.3.3. Profitability by Market Segments 15.1.3.4. Sales Footprint 15.1.3.5. Strategy Overview 15.1.3.5.1. Marketing Strategy 15.1.4. Steelcase Inc. 15.1.4.1. Overview 15.1.4.2. Product Portfolio 15.1.4.3. Profitability by Market Segments 15.1.4.4. Sales Footprint 15.1.4.5. Strategy Overview 15.1.4.5.1. Marketing Strategy 15.1.5. Krueger International 15.1.5.1. Overview 15.1.5.2. Product Portfolio 15.1.5.3. Profitability by Market Segments 15.1.5.4. Sales Footprint 15.1.5.5. Strategy Overview 15.1.5.5.1. Marketing Strategy 15.1.6. Sauder MFG 15.1.6.1. Overview 15.1.6.2. Product Portfolio 15.1.6.3. Profitability by Market Segments 15.1.6.4. Sales Footprint 15.1.6.5. Strategy Overview 15.1.6.5.1. Marketing Strategy 15.1.7. Nemschoff 15.1.7.1. Overview 15.1.7.2. Product Portfolio 15.1.7.3. Profitability by Market Segments 15.1.7.4. Sales Footprint 15.1.7.5. Strategy Overview 15.1.7.5.1. Marketing Strategy 15.1.8. HERDEGEN 15.1.8.1. Overview 15.1.8.2. Product Portfolio 15.1.8.3. Profitability by Market Segments 15.1.8.4. Sales Footprint 15.1.8.5. Strategy Overview 15.1.8.5.1. Marketing Strategy 15.1.9. Honigberg International 15.1.9.1. Overview 15.1.9.2. Product Portfolio 15.1.9.3. Profitability by Market Segments 15.1.9.4. Sales Footprint 15.1.9.5. Strategy Overview 15.1.9.5.1. Marketing Strategy 15.1.10. DeVilbiss Healthcare 15.1.10.1. Overview 15.1.10.2. Product Portfolio 15.1.10.3. Profitability by Market Segments 15.1.10.4. Sales Footprint 15.1.10.5. Strategy Overview 15.1.10.5.1. Marketing Strategy 15.1.11. Krug Inc. 15.1.11.1. Overview 15.1.11.2. Product Portfolio 15.1.11.3. Profitability by Market Segments 15.1.11.4. Sales Footprint 15.1.11.5. Strategy Overview 15.1.11.5.1. Marketing Strategy 16. Assumptions & Acronyms Used 17. Research Methodology
Explore Healthcare Insights
View Reports
Patient Recliners Market
